PT 141 10mg

Description

========================
PT-141 — Research Melanocortin Agonist
========================
Class: MC3R/MC4R agonist; CNS arousal-circuit research

Research Focus (non-clinical):
• Hypothalamic melanocortin signaling linked to desire/arousal
• Dopaminergic reward/motivation coupling vs. peripheral NO pathways
• Comparative studies vs. PDE5-pathway probes (central vs. peripheral mechanisms)

Notes for Investigators:
Used to interrogate central melanocortin pathways affecting sexual motivation independent of vasodilatory cascades.

Regulatory & Use
• Laboratory research only. Not for human or veterinary use. No therapeutic or dosing claims.

PT-141 10mg Research Peptide

PT-141, also known as Bremelanotide, is a synthetic peptide widely used in laboratory and research settings. Researchers study PT-141 for its interaction with melanocortin receptors and its role in neuropeptide signaling pathways. PT-141 has become a compound of interest in preclinical research focused on receptor activity and biological response mechanisms.

Research Applications

PT-141 is commonly used in experimental studies involving melanocortin receptor pathways. Scientists investigate PT-141 to better understand signaling processes, receptor interactions, and neuropeptide activity. Ongoing research continues to explore the potential applications of PT-141 in controlled laboratory environments.

PT-141 Product Features

• 10mg PT-141 peptide per vial
• Third-party tested for quality
• Certificate of Analysis (COA) available
• High-purity research material
• Research use only

Storage and Handling

Store PT-141 in a cool, dry place away from direct sunlight and moisture. Proper storage helps maintain product integrity during laboratory use. Follow standard laboratory handling procedures when working with PT-141 research materials.

Research Use Disclaimer

PT-141 is supplied strictly for laboratory and research purposes. This product is not intended for human consumption, medical use, diagnosis, treatment, cure, or prevention of any disease. PT-141 should only be handled by qualified professionals in appropriate research environments.